|
 |
|
Occult Blood: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Occult Blood testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
 |
|
$750.00 |
| |
|
|
|
PAP: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of PAP testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
PSA: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of PSA testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Thyroglobulin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Thyroglobulin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Vitamin B-12: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Vitamin B-12 testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Amphetamines: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Amphetamines testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Barbiturates: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Barbiturates testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Benzodiazepines: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Benzodiazepines testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Cannabinoids/Marijuana: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Cannabinoids/Marijuana testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Cocaine: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Cocaine testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
LSD: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of LSD testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Methadone: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Methadone testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Methaqualone: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Methaqualone testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Opiates: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Opiates testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Phencyclidine: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Phencyclidine testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Propoxyphene: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Propoxyphene testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
Tricyclic Antidepressants: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations-- France, Germany, Italy, Japan, Spain, UK, USA
This new report from VPGMarketResearch.com provides analysis of Tricyclic Antidepressants testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.
|
|
|
$750.00 |
| |
|
|
|
POC Lipid Testing Market: US, Germany, Spain--Physician Offices, Emergency Rooms, Ambulatory Care Centers
This new 340-page report from Venture Planning Group contains 36 tables, and provides a comprehensive analysis of the POC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market.
|
|
|
$0.00 |
| |
|
|
|
|